Engaging stakeholders to level up COPD care in LMICs: lessons learned from the ""Breathe Well"" programme in Brazil, China, Georgia, and North Macedonia

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
FERNANDES, Genevie
WILLIAMS, Sian
ADAB, Peymane
GALE, Nicola
JONG, Corina de
SOUSA, Jaime Correia de
CHENG, Kk
CHI, Chunhua
COOPER, Brendan G.
DICKENS, Andrew P.
Citação
BMC HEALTH SERVICES RESEARCH, v.24, n.1, article ID 66, 10p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundEffective stakeholder engagement in health research is increasingly being recognised and promoted as an important pathway to closing the gap between knowledge production and its use in health systems. However, little is known about its process and impacts, particularly in low-and middle-income countries. This opinion piece draws on the stakeholder engagement experiences from a global health research programme on Chronic Obstructive Pulmonary Disease (COPD) led by clinician researchers in Brazil, China, Georgia and North Macedonia, and presents the process, outcomes and lessons learned.Main bodyEach country team was supported with an overarching engagement protocol and mentored to develop a tailored plan. Patient involvement in research was previously limited in all countries, requiring intensive efforts through personal communication, meetings, advisory groups and social media. Accredited training programmes were effective incentives for participation from healthcare providers; and aligning research findings with competing policy priorities enabled interest and dialogue with decision-makers. The COVID-19 pandemic severely limited possibilities for planned engagement, although remote methods were used where possible. Planned and persistent engagement contributed to shared knowledge and commitment to change, including raised patient and public awareness about COPD, improved skills and practice of healthcare providers, increased interest and support from clinical leaders, and dialogue for integrating COPD services into national policy and practice.ConclusionStakeholder engagement enabled relevant local actors to produce and utilise knowledge for small wins such as improving day-to-day practice and for long-term goals of equitable access to COPD care. For it to be successful and sustained, stakeholder engagement needs to be valued and integrated throughout the research and knowledge generation process, complete with dedicated resources, contextualised and flexible planning, and commitment.
Palavras-chave
Stakeholder engagement, COPD, Research impact, Translation, LMICs
Referências
  1. Abimbola S, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005802
  2. Adeloye D, 2022, LANCET RESP MED, V10, P447, DOI 10.1016/S2213-2600(21)00511-7
  3. Bloom D.E., 2012, PROGRAM GLOBAL DEMOG
  4. Boaz A, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0337-6
  5. Brakema EA, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1255-z
  6. Concannon TW, 2019, J GEN INTERN MED, V34, P458, DOI 10.1007/s11606-018-4738-6
  7. Cuppen E, 2016, Foresight in Organizations Methods and Tools, P208
  8. Deverka PA, 2012, J COMP EFFECT RES, V1, P181, DOI 10.2217/CER.12.7
  9. Dickens A, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA905
  10. Evidence policy impact, 2021, WHO guide for evidence-informed decision-making
  11. Gjorgjievski D., 2020, Open Access Macedonian Journal of Medical Sciences, V8, P27, DOI 10.3889/oamjms.2020.4519
  12. Glandon D, 2017, HEALTH POLICY PLANN, V32, P1457, DOI 10.1093/heapol/czx123
  13. Habib GMM, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020384
  14. Hristovska BM, 2022, Tobacco Farming and the Effects of Tobacco Subsidies in North Macedonia
  15. Iheanacho I, 2020, INT J CHRONIC OBSTR, V15, P439, DOI 10.2147/COPD.S234942
  16. International Primary Care Respiratory Group (IPCRG), The WHO and IPCRG in a joint webinar call for health professionals to be leaders and role models to help reduce tobacco use in 2021
  17. Janic A, 2020, OPHTHALMOL THER, V9, P221, DOI 10.1007/s40123-020-00246-w
  18. Khoo EM, 2021, LANCET, V398, P488, DOI 10.1016/S0140-6736(21)01230-7
  19. Kingdon J. W., 1984, AGENDAS ALTERNATIVES
  20. Kok MO, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0107-2
  21. Li X, 2017, LANCET, V390, P2584, DOI 10.1016/S0140-6736(17)33109-4
  22. Maglakelidze M, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-056902
  23. Martins SM, 2022, NPJ PRIM CARE RESP M, V32, DOI 10.1038/s41533-022-00303-w
  24. Mendelow AL., 1981, Proc Int Conf Inf Syst, V20, P407
  25. Michels NRM, 2018, EDUC PRIM CARE, V29, P322, DOI 10.1080/14739879.2018.1517391
  26. National Health and Family Planning Commission of the People. National Health and Family Planning Commission of the People's Republic of China, 2016, The 13th Five-Year Plan for Healthcare
  27. National Health Service (NHS) Institute for Innovation and Improvement, 2009, The organising for quality and value: Delivering improvement programme
  28. Pan ZH, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-051811
  29. Pang H, 2022, NPJ PRIM CARE RESP M, V32, DOI 10.1038/s41533-022-00286-8
  30. Patil R, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.03072
  31. Rossaki FM, 2021, EXPERT REV RESP MED, V15, P1563, DOI 10.1080/17476348.2021.1985762
  32. Scott I, 2021, GLOB PUBLIC POLICY G, V1, P20, DOI 10.1007/s43508-021-00004-z
  33. Spasovski M., 2018, Tob Prev Cess, V4, pA183
  34. University of Birmingham, 2022, BREATHE WELL: Building Research Across the World in Lung Disease
  35. Van Schayck OCP, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0039-5
  36. Wang C, 2018, LANCET, V391, P1706, DOI [10.1016/s0140-6736(18)30841-9, 10.1016/S0140-6736(18)30841-9]
  37. World Health Organization, 2021, CHRONIC OBSTRUCTIVE
  38. Xie M, 2020, RESP RES, V21, DOI 10.1186/s12931-020-1291-8